Cargando…
Differential involvement of Ras-GRF1 and Ras-GRF2 in L-DOPA-induced dyskinesia
OBJECTIVE: Recent findings have shown that pharmacogenetic manipulations of the Ras-ERK pathway provide a therapeutic means to tackle l-3,4-dihydroxyphenylalanine (l-DOPA)-induced dyskinesia (LID). First, we investigated whether a prolonged l-DOPA treatment differentially affected ERK signaling in m...
Autores principales: | Bido, Simone, Solari, Nicola, Indrigo, Marzia, D’Antoni, Angela, Brambilla, Riccardo, Morari, Michele, Fasano, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479526/ https://www.ncbi.nlm.nih.gov/pubmed/26125041 http://dx.doi.org/10.1002/acn3.202 |
Ejemplares similares
-
RasGrf1 and Aging
por: Davies, Kelvin J. A., et al.
Publicado: (2011) -
RasGrf1: genomic imprinting, VSELs, and aging
por: Ratajczak, Mariusz Z., et al.
Publicado: (2011) -
RasGrf1 deficiency delays aging in mice
por: Borrás, Consuelo, et al.
Publicado: (2011) -
Nicotine self-administration and ERK signaling are altered in RasGRF2 knockout mice
por: Morella, Ilaria, et al.
Publicado: (2022) -
RasGRF1 regulates proliferation and metastatic behavior of human alveolar rhabdomyosarcomas
por: TARNOWSKI, MACIEJ, et al.
Publicado: (2012)